| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| BCG from Calmette-Guerin strain | Injection | N/A | |
| filgrastim | Injection | 300 mcg/ml | |
| flutamide | Tablet | 250 mg | |
| interferon alpha 2B | Injection | 18 000 000 UI | |
| letrozol | Tablet | 2.5 mg | |
| leuprorelin | Injection | 3.75 mg (acetate) | |
| tamoxifen | Tablet | 20 mg (as citrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorambucil | Tablet | 2 mg | |
| cyclophosphamide | Injection | 500 mg | |
| cyclophosphamide | Tablet | 50 mg | |
| dacarbazine | Injection | 200 mg | |
| ifosfamide | Injection | 1 g | |
| melphalan | Tablet | 2 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| etoposide | Injection | 20 mg/mL | |
| vinblastine | Injection | 10 mg | |
| vincristine | Injection | 1 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| capecitabine | Tablet | 500 mg | |
| citarabine | Injection | 100 mg | |
| citarabine | Injection | 500 mg | |
| fluorouracil | Injection | 500mg/10ml | |
| gemcitabine | Injection | 1g (chlorohydrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| fludarabine | Injection | 50 mg (phosphate) | |
| mercaptopurine | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dactinomycin | Solution for injection | 0.5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| methotrexate | Injection | 500mg (sodium) | |
| methotrexate | Solution for injection | 25 mg/ ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| doxorubicin | Powder for injection | 50 mg (hydrochloride) in vial | |
| mitoxantrone | Injection | 2 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| imatinib | Tablet | 100 mg (as mesylate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| rituximab | Solution for injection | 10 mg/ ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| asparaginase | Injection | 10000 UI | |
| hydroxyurea | Capsule | 500 mg | |
| retinoic acid | Capsule | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carboplatin | Injection | 150 mg | |
| carboplatin | Injection | 450 mg | |
| cisplatin | Injection | 50 mg | |
| oxaliplatin | Injection | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| paclitaxel | Powder for injection | 6 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| filgrastim | Injection | 300 mcg/ml | |
| interferon alpha 2B | Injection | 18 000 000 UI |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| azathioprine | Tablet | 50 mg | |
| basiliximab | Injection | 10 mg | |
| cyclosporine | Solution | 100 mg/ml | |
| leflunomide | Tablet | 20 mg | |
| methotrexate | Tablet | 2.5 mg | |
| mycophenolate mofetil | Tablet | 250 mg | |
| tacrolimus | Tablet | 1 mg | |
| talidomida | Tablet | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amikacin | Injection | 250 mg/ml | |
| amoxicillin | Oral liquid | 250 mg/5 mL | |
| amoxicillin | Tablet | 500 mg | |
| amoxicillin + clavulanic acid | Oral liquid | 250 mg amoxicillin + 62.5 mg clavulanic acid/5 ml | |
| amoxicillin + clavulanic acid | Tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
| ampicillin | Powder for injection | 1 g (as sodium salt) in vial | |
| ampicillin + sulbactam | Powder for injection | 1 g (sodium) + 0.5 g (sodium) | |
| azithromycin | Oral liquid | 200 mg/5 mL | |
| azithromycin | Tablet | 500 mg | |
| benzathine benzylpenicillin | Injection | 1 200 000 IU | |
| cefadroxil | Capsule | 500mg | |
| cefadroxil | Oral liquid | 250mg/5ml | |
| cefazolin | Injection | 1g | |
| cefotaxime | Injection | 1 g | |
| ceftazidime | Powder for injection | 1 g (as pentahydrate) in vial | |
| ceftriaxone | Powder for injection | 1 g (as sodium salt) in vial | |
| Chloranfenicol | Capsule | 1 gr (sodium succinate) | |
| ciprofloxacin | Injection | 2mg (lactate)/ml | |
| ciprofloxacin | Tablet | 500mg (as chlorohydrate) | |
| clarithromycin | Suspension | 250 mg/5 ml | |
| clarithromycin | Tablet | 500 mg | |
| clindamycin | Injection | 150 mg (as phosphate)/mL | |
| clindamycin | Oral liquid | 75 mg/5 mL (as palmitate) | |
| clindamycin | Tablet | 300 mg | |
| dicloxacillin | Tablet | 250mg | |
| doxycycline | Capsule | 100 mg (as hydrochloride or hyclate) | |
| gentamicin | Injection | 40 mg/ml | |
| imipenem + cilastatin | Powder for injection | 500 mg (as monohydrate) + 500 mg (as sodium salt) in vial | |
| kanamycin | Injection | 500 mg | |
| kanamycin | Powder for injection | 1 g (as sulfate) in vial | |
| levofloxacin | Injection | 5 mg/ ml | |
| levofloxacin | Injection | 500 mg | |
| linezolid | injection for intravenous administration | 2 mg/ ml | |
| linezolid | Tablet | 600 mg | |
| meropenem | Powder for injection | 1 g | |
| meropenem | Powder for injection | 500mg | |
| metronidazole | Injection | 5 mg/mL | |
| moxifloxacin | Tablet | 400 mg | |
| nitrofurantoin | Oral suspension | 50mg/5ml | |
| nitrofurantoin | Tablet | 100 mg | |
| oxacillin | Injection | 1g | |
| penicillin G (Sodium) | Powder for injection | 5 MUI | |
| phosphomycin | Capsule | 500 mg | |
| piperacillin sodium + tazobactum sodium | Solution for injection | 4 g/ 500 mg | |
| streptomycin | Powder for injection | 1 g | |
| sulfadiazine | Tablet | 500 mg | |
| sulfamethoxazole + trimethoprim | Oral liquid | 200 mg + 40 mg/5 mL | |
| sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg | |
| vancomycin | Injection | 500 mg (chlorohydrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clofazimine | Capsule | 100 mg | |
| clofazimine | Capsule | 50 mg | |
| cycloserine | Capsule | 250 mg | |
| dapsone | Tablet | 100 mg | |
| ethambutol | Tablet | 400mg (chlorohydrate) | |
| ethambutol + isoniazid + pyrazinamide + rifampicin | Tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
| ethionamide | Tablet | 250 mg | |
| ethionamide | Tablet | 500 mg | |
| isoniazid | Oral liquid | 50 mg/5 ml | |
| isoniazid | Tablet | 100mg | |
| isoniazid | Tablet | 300mg | |
| isoniazid + rifampicin | Tablet | 150 mg + 150 mg | |
| p-aminosalicylic acid | Granules | 4 g in sachet | |
| p-aminosalicylic acid | Tablet | 500 mg | |
| pyrazinamide | Tablet | 500 mg | |
| rifampicin | Capsule | 300 mg | |
| rifampicin | Suspension | 100mg/5ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amphotericin B | Injection | 50 mg | |
| fluconazole | Capsule | 50 mg | |
| fluconazole | Injection | 2 mg/mL in vial | |
| fluconazole | Injection | 200 mg | |
| itraconazole | Tablet | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| abacavir (ABC) | Tablet | 300 mg | |
| aciclovir | Oral liquid | 200 mg/5 mL | |
| aciclovir | Tablet | 250 mg | |
| aciclovir | Tablet | 400 mg | |
| atazanavir | Solid oral dosage form | 300 mg (as sulfate) | |
| darunavir | Tablet | 600 mg | |
| didanosine (ddI) | Capsule (unbuffered enteric-coated) | 125 mg | |
| didanosine (ddI) | Capsule (unbuffered enteric-coated) | 250 mg | |
| didanosine (ddI) | Capsule (unbuffered enteric-coated) | 400 mg | |
| didanosine (ddI) | Powder for oral administration | 4g | |
| efavirenz (EFV or EFZ) | Capsule | 200 mg | |
| efavirenz (EFV or EFZ) | Tablet | 600 mg | |
| efavirenz (EFV or EFZ) | Tablet | 600 mg | |
| efavirenz + emtricitabine + tenofovir | Tablet | 600 mg + 200 mg + 300 mg | |
| emtricitabine + tenofovir | Tablet | 200 mg + 300 mg | |
| estavudina | Capsule | 30 mg | |
| etravirine | Tablet | 100 mg | |
| ganciclovir | Injection | 500 mg (sodium) | |
| indinavir (IDV) | Solid oral dosage form | 400 mg (as sulfate) | |
| lamivudine (3TC) | Oral liquid | 50 mg/5 ml | |
| lamivudine (3TC) | Tablet | 150 mg | |
| lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
| lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
| lopinavir + ritonavir (LPV/r) | Tablet | 200 mg/ 50 mg | |
| nelfinavir | Oral liquid | 50mg (mesylate)/g | |
| nelfinavir | Tablet | 250mg (as mesylate) | |
| nevirapine (NVP) | Oral liquid | 50 mg/5 ml | |
| nevirapine (NVP) | Tablet | 200 mg | |
| oseltamivir | Capsule | 75 mg (as phosphate) | |
| raltegavir | Tablet | 400 mg | |
| ritonavir | Capsule | 100 mg | |
| ritonavir | Oral liquid | 400 mg/5 ml | |
| stavudine (d4T) | Capsule | 20 mg | |
| stavudine (d4T) | Powder for oral liquid | 5 mg/5 ml | |
| tenofovir disoproxil fumarate | Tablet | 300 mg | |
| zidovudine (ZDV or AZT) | Capsule | 100 mg | |
| zidovudine (ZDV or AZT) | Capsule | 300 mg | |
| zidovudine (ZDV or AZT) | Suspension | 10 mg/ml | |
| zidovudine (ZDV or AZT) | Suspension | 50 mg/5 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| anti rabies human serum | Solution for injection | 150 UI/ ml | |
| anti-D immunoglobulin (human) | Injection | 300 mcg/ ml | |
| antitetanus immunoglobulin (human) | Intramuscular administration | 250 IU per vial | |
| human normal immunoglobulin | Injectable solution | (5 - 6) g | |
| human normal immunoglobulin | Injectable solution | 1 gr | |
| ophidic antivenom | Solution for injection | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cell-culture rabies vaccine | Injection | N/A | |
| DT vaccine | Injection | N/A | |
| DTP vaccine | Injection | Injectiondiphtheria-tetanus toxoid + whole inactivated B. pertussis cells | |
| hepatitis B vaccine | Injection | N/A | |
| measles vaccine | Injection | N/A | |
| monovalent human atenuate rotavirus vaccine | Injection | 1 mL | |
| pentavalent vaccine | Injection | diphtheria-tetanu toxoid, whole cell pertussis, hepatitis B, H. influenzae b (Hib) | |
| pneumococcal vaccine -23 | Solution for injection | 0.5 mL - 1 dose | |
| pneumococcal vaccine 10 valente | suspension inyectable | N/A | |
| pneumococcal vaccine 13 valente | suspension inyectable | N/A | |
| poliomyelitis vaccine | Injection | N/A | |
| polyomelitis bivalent vaccine | Injection | 0.1 mL | |
| Td Difteria Toxoid + Tetanus adsorbe vaccine | Injection | N/A | |
| Tdap Acellular Triple Antibacterial Vaccine | Injection | D2LF, P2.5mcg,T5LF | |
| trivalent anti-influenza vaccine | Injection | 0.5 mL (A+B+Subviron, Timerosal) | |
| vero cells purified rabies vaccine | Injection | N/A | |
| yellow fever vaccine | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| albendazole | Tablet | 200mg | |
| mebendazole | Suspension | 100mg/5ml | |
| mebendazole | Tablet | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benznidazole | Tablet | 100 mg | |
| chloroquine | Tablet | 150mg (phosphate) | |
| diloxanide | Oral suspension | (200-250)mg/5mL | |
| diloxanide | Tablet | 500 mg (furoate) | |
| hydroxychloroquine | Tablet | 400mg (sulfate) or 310mg (pure) | |
| meglumine antimoniate | Injection | 300mg/ml | |
| metronidazole | Suspension | 250 mg/5 mL | |
| metronidazole | Tablet | 500 mg | |
| nifurtimox | Tablet | 120 mg | |
| primaquine | Tablet | 15 mg (phosphate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| permethrin | Cream | 5% | |
| permethrin | Lotion | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| neomycin + bacitracin | Cream | 5 mg (5000 UI) + 5 mg (250 UI) | |
| silver sulfadiazine | Cream | 1% | |
| sodium fusidate | Ointment | 2% (20 mg/g) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clotrimazole | Cream | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| methoxsalen | Solution | 0.4% | |
| methoxsalen | Tablet | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aluminum aulfate and aalcium acetate | Solution | (36.4 + 51.8) % | |
| nitrofurazone | Cream | 0.2% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| tretinoin | Cream | 0.05 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| betamethasone | Cream | 0.1% (as valerate) | |
| hydrocortisone | Cream | 1% (acetate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetazolamide | Tablet | 250 mg | |
| aciclovir | Eye ointment | 3% | |
| artificial tears | Solution (eye drops) | 0.3% to 1% | |
| atropine | Solution (eye drops) | 0.5-1% | |
| carbacol | eye drops | 0.01% | |
| Chloranfenicol | eye drops | 0.5% | |
| Chloranfenicol | eye drops | 1% | |
| chloranfenicol + dexametasone phosphate | eye drops | 0.3%+0.1% | |
| ciprofloxacin | Topical | 0.3% drops (as hydrochloride) | |
| cromoglycate | Solution (eye drops) | 2% (sodium) | |
| cyclopentolate | Solution (eye drops) | 1% (hydrochloride) | |
| diclofenac | Solution (eye drops) | 0.1% (sodium) | |
| dorzolamide | Solution (eye drops) | 2% | |
| latanoprost | Solution (eye drops) | 0.005% | |
| normal saline | Solution (eye drops) | 500 mL | |
| oxitetracycline + plymyxine B | eye drops | (5 mg +10,000 U.I)/g | |
| phenylephrine | dro | 10% | |
| phenylephrine+tropicamide | Solution (eye drops) | 0.8% - 5 mL. | |
| pilocarpine | Solution (eye drops) | 2% (hydrochloride or nitrate) | |
| polyacrilic acid | eye drops | 0.2% | |
| prednisolone | Solution (eye drops) | 1% (acetate) | |
| tetracaine | Solution (eye drops) | 0.5% (hydrochloride) | |
| timolol | Solution (eye drops) | 0.5% (maleate) | |
| tobramycin | dro | 0.3% x 5 ml | |
| tobramycin + dexamethasone | dro | 0.3%/ 0.1% x 5 ml | |
| tropicamide | Solution (eye drops) | 0.5% | |
| tropicamide | Solution (eye drops) | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| glycerine | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dexamethasone | Injection | 4 mg/mL | |
| fludrocortisone | Tablet | 0.1 mg | |
| hydrocortisone | suspension inyectable | 500 mg | |
| methylprednisolone | Injection | 1 gm | |
| methylprednisolone | Injection | 500 mg (sodium succinate) | |
| methylprednisolone | Tablet | 40 mg | |
| prednisolone | Tablet | 5 mg | |
| prednisone | Tablet | 50 mg | |
| triamcinolone | Injection | 10 mg/mL in 5-mL vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| desmopressin | Nasal solution | 0.1 mg (acetate)/mL | |
| octreotide | Solution for injection | 0.1 mg/mL - 1mL | |
| oxytocin | Injection | 5 IU/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| levothyroxine | Tablet | 100 mcg (sodium salt) | |
| levothyroxine | Tablet | 50 mcg (sodium salt) | |
| methimazole | Tablet | 5 mg | |
| propylthiouracil | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 80 to 100 mg | |
| clopidogrel | Tablet | 75 mg | |
| enoxaparin | Injection | 20 mg/ml | |
| enoxaparin | Injection | 60 mg (sodium) | |
| heparin sodium | Injection | 5000 IU/mL in 1-mL ampoule | |
| streptokinase | Powder for injection | 1.5 million IU in vial | |
| warfarin | Tablet | 5 mg (sodium salt) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aminocaproic acid | Injection | 250mg/ml | |
| factor IX | Powder for injection | 500 UI a 600 UI | |
| factor VIII | Solution for injection | 500 UI | |
| phytomenadione | Injection | 10 mg/mL in 1-mL vial | |
| prothrombin complex concentrate | Injection | 500 a 600 UI | |
| prothrombine activate complex (CCPa) or anticoagulant anti-inhibitor complex | Injection | 500 UF |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cyanocobalamin | Injection | 1000 mcg/ml | |
| erythropoietin alpha | Injection | 4000 U/ ml | |
| erythropoietin beta | Solution for injection | 50000 UI | |
| ferrous sulfate | Oral liquid | 125mg/ml | |
| ferrous sulfate | Tablet | 300 mg | |
| ferrous sulfate + folic acid | Tablet | 300mg + 0.5mg | |
| folic acid | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| albumin | Injection | 20%-25% | |
| calcium chloride | Injection | 5% | |
| chloruro de sodio | Parenteral solution | 20% | |
| chloruro de sodio | Solution for injection | 0.9 % | |
| dextrose | Injection | 10% | |
| dextrose | N/A | 5% | |
| dextrose | N/A | 50% | |
| dextrose + sodium chlorure | Solution for injection | 5% + 0.9% - 1000 mL. | |
| dextrose + sodium chlorure | Solution for IV infusion | 5 + 0.3% | |
| hemodialysis solution | Solution for IV infusion | N/A | |
| hemodialysis solution (concentrated, acid, for bicarbonate hemodialysis) | N/A | N/A | |
| intraperitoneal dialysis solution (of appropriate composition) | Parenteral formulation | 4.5% | |
| intraperitoneal dialysis solution (of appropriate composition) | Solution for IV infusion | 2.5% glucose | |
| magnesium sulfate | Injection | 50% x 2 ml | |
| mannitol | Intravenous administration | 20% | |
| peritoneal dialysis solution | Solution | Dextrose 1.5% - 2000 mL. | |
| plasmatic volumen expander gelatin based | Solution | 3.5-4% | |
| potassium chloride | Injection | 20 mEq/10 ml | |
| potassium chloride | Solution | 2 mEq/ml | |
| ringer lactate solution | N/A | N/A | |
| sodium bicarbonate | Injection | 8.4% | |
| sodium chloride + phenol (preservant) | Injection | 0.9 + 0.4% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atenolol | Tablet | 100 mg | |
| esmolol | Injection | 250 mg/ml | |
| propranolol | Injection | 1mg/ml | |
| propranolol | Tablet | 10mg (hydrochloride) | |
| propranolol | Tablet | 40 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carvedilol | Tablet | 25 mg | |
| carvedilol | Tablet | 6.25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amlodipine | Injection | 5 mg/mL | |
| amlodipine | Tablet | 5 mg (besylate) | |
| nifedipine | N/A | 30 mg | |
| nifedipine | Tablet | 10 mg | |
| nimodipine | Injection | 0.2 mg/mL | |
| nimodipine | Tablet | 30 mg | |
| nimodipine | Tablet | 30 mg. | |
| verapamil | Injection | 2.5 mg/mL | |
| verapamil | N/A | 240 mg | |
| verapamil | Tablet | 80 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| enalapril | Tablet | 20 mg (maleate) | |
| enalapril | Tablet | 5 mg (as hydrogen maleate) | |
| Ibersartan | Tablet | 150 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atorvastatine | Tablet | 10 mg | |
| atorvastatine | Tablet | 40 mg (calcium salt) | |
| ciprofibrato | Capsule | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| hydralazine | Injection | 20 mg/ ml | |
| hydralazine | Tablet | 50 mg (hydrochloride) | |
| methyldopa | Tablet | 500mg | |
| sodium nitroprusside | Injection | 25 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
| furosemide | Tablet | 40 mg | |
| hydrochlorothiazide | Tablet | 25 mg | |
| spironolactone | Tablet | 100mg | |
| spironolactone | Tablet | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amiodarone | Injection | 50 mg/ml | |
| amiodarone | Tablet (HCI) | 200 mg (hydrochloride) | |
| digoxin | eli | 0.05 mg/ml | |
| digoxin | Injection | 0.25 mg/ml | |
| digoxin | Tablet | 0.25 mg | |
| dobutamine | Injection | 12.5mg (hydrochloride)/mL in 20 ml vial | |
| dopamine | Injection | 40 mg/ml | |
| ephedrine | Injection | 25 mg/ml | |
| epinephrine (adrenaline) | Injection | 1 mg in 1-mL ampoule | |
| glyceryl trinitrate | Patch | 18-25 mg | |
| glyceryl trinitrate | Solution for injection | 5 mg/ ml | |
| isosorbide dinitrate | Tablet | 40 mg | |
| isosorbide dinitrate | Tablet (sublingual) | 5 mg | |
| norepinephrine | Injection | 1 mg (bitartrate)/mL | |
| phenylephrine | Injection | 10 mg in 1-mL ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| antihemorrhoidal preparation (corticosteroid + local anesthetic) | Ointment | 30 gr/ 60 gr. | |
| polidocanol | Intravenous administration | 3% in 20-mL ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clotrimazole | Vaginal cream | 1% | |
| metronidazole | Gel | 0.75% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chorionic gonadotropin | Injection | 2500 UI | |
| clomifene | Tablet | 50 mg (citrate) | |
| conjugated estrogens | Tablet | 0.625 mg | |
| danazol | Tablet | 200 mg | |
| estradiol | Tablet | 1 mg | |
| ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 150 mcg | |
| etonogestrel | implant | 68 mg. | |
| levonorgestrel | implant | 75 mg | |
| levonorgestrel | Tablet | 1.5 mg | |
| medroxyprogesterone | Powder for injection | 150 mg in vial | |
| norethisterone enantate + estradiol valerate | Injection | 50 mg/5 mg | |
| progesterone | Tablet | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bromocriptine mesylate | Tablet | 2.5 mg | |
| ergonovina maleato | Injection | 0.2 mg/ ml | |
| misoprostol | Tablet | 200 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| oxibutinine hidrochloride | Tablet | 5mg. | |
| terazosin | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alendronic acid | Tablet | 70mg (as alendronate sodium) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| allopurinol | Tablet | 300 mg | |
| colchicine | Tablet | 0.5mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| diclofenac | Injection | 25 mg (sodium)/mL | |
| diclofenac | Suspension | 15mg/5mL | |
| diclofenac (sodium) | Tablet | 50mg | |
| ibuprofen | Suspension | 100 mg/5 mL | |
| ibuprofen | Tablet | 400 mg | |
| indomethacin | Tablet | 25 mg | |
| ketorolac | Injection | 30mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cisatracurium | Injection | 2 mg/ml | |
| metocarbamol | Injection | 500mg | |
| orfenadrine | Injection | 30mg (citrate)/ml in 2ml vial | |
| pancuronium | Injection | 2 mg (bromuro)/mL | |
| suxamethonium | Injection | 100mg/ml | |
| suxamethonium | Injection | 500mg | |
| Tizanidine hydrochloride | Tablet | 4 mg. | |
| vecuronium | Injection | 4 mg (bromide)/mL in ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetaminofen | Tablet | 125 mg | |
| acetaminofen | Tablet | 250 -300 mg | |
| acetaminofen | Tablet | 500 mg | |
| acetaminofen + oxycodone | Tablet | 325+5 mg | |
| ergotamine + caffeine | Tablet | 1 mg (tartrate) + 100 mg | |
| fentanyl | Injection | 0.05 mg/mL | |
| morphine | Oral liquid | 10 mg (sulfate)/5 mL | |
| morphine | Tablet | 30 mg (sulfate) | |
| nalbuphine hydrochloride | Solution for injection | 10 mg/ml | |
| oxycodone | Tablet | 10 mg | |
| paracetamol + acetaminophen | Syrup | 120 mg/ 5 ml | |
| pethidine | Injection | 50 mg (hydrochloride) in 1-mL ampoule | |
| tramadol | Injection | 50 mg (hydrochloride)/mL | |
| tramadol | Oral liquid | 100 mg (hydrochloride)/mL (as drops) | |
| tramadol | Tablet | 50 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bupivacaine | Injection | 0.5% (hydrochloride) in vial | |
| bupivacaine + dextrosa | Injection | 0.5%/ 8% (80 mg/ ml) | |
| etomidate | Injection | 2mg/ml | |
| halothane | Inhalation | N/A | |
| isoflurane | Inhalation | N/A | |
| ketamine | Injection | 50 mg/mL | |
| lidocaine | Injection | 2% (hydrochloride) in vial | |
| lidocaine | Solution topical | 10% (100mg/mL) | |
| lidocaine + epinephrine (adrenaline) | Injection | 2% | |
| mepivacaina + epinefrina | Injection | 2% / 1:100 000 | |
| mepivacaine | Dental cartridge | 3% | |
| propofol | Injection | 10 mg/mL | |
| propofol | Injection | 20 mg/mL | |
| remifentanil | Injection | 2 mg | |
| remifentanil | Injection | 5mg | |
| sevoflurane | Inhalation | N/A | |
| thiopental | Injection | 1 g (as sodium) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carbamazepine | Tablet | 200 mg | |
| clonazepam | Tablet | 2mg | |
| levetiracetam | Tablet | 500 mg | |
| oxcarbazepine | N/A | 60mg/mL | |
| phenobarbital | Oral liquid | 20 mg/5mL (0.4%) | |
| phenobarbital | Suspension | 65mg/mL | |
| phenobarbital | Tablet | 100 mg | |
| phenytoin | Injection | 50 mg/mL in 5-mL vial (sodium salt) | |
| phenytoin | Solid oral dosage form | 100 mg (sodium salt) | |
| phenytoin | Suspension | 125 mg/ 5 ml x 240 ml | |
| topiramate | Tablet | 25 mg | |
| valproic acid (sodium valproate) | Injection | 100mg/mL | |
| valproic acid (sodium valproate) | Oral liquid | 250 mg/5 mL | |
| valproic acid (sodium valproate) | Solution | 200 mg/ml | |
| valproic acid (sodium valproate) | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amantadine | Capsule | 100 mg | |
| biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
| biperiden | Tablet | 2 mg (hydrochloride) | |
| levodopa + carbidopa | Tablet | 250 mg + 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| methadone | Concentrate for oral liquid | 10 mg/ml (hydrochloride) | |
| neostigmine | Injection | 0,5 mg/ml | |
| pyridostigmine | Tablet | 60 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amitriptyline | Tablet | 25 mg (hydrochloride) | |
| caffeine citrate | Injection | 20 mg/ml | |
| clomipramine | Tablet | 25 mg | |
| duloxetine | Tablet | 60 mg | |
| fluoxetine | Tablet | 20 mg | |
| imipramine chlorohydrate | Tablet | 10 mg | |
| imipramine chlorohydrate | Tablet | 25mg | |
| memantina | Tablet | 10 mg | |
| methylphenidate | Tablet | 10 mg (hydrochloride) | |
| sertraline | Tablet | 50 mg (chlorohydrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
| chlorpromazine | Tablet | 100 mg (hydrochloride) | |
| clozapine | Tablet | 100mg | |
| diazepam | Injection | 5 mg/mL | |
| flufenazine decanoate | N/A | 25mg/mL | |
| haloperidol | Injection | 5 mg (decanoate)/mL | |
| haloperidol | Oral liquid | 2 mg/mL | |
| haloperidol | Tablet | 5 mg | |
| lithium carbonate | Tablet | 300 mg | |
| lorazepam | Tablet | 2 mg. | |
| midazolam | Injection | 5 mg/mL | |
| olanzapine | Tablet | 10 mg | |
| risperidone | Solution | 1 mg/ml | |
| risperidone | Tablet | 2mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aminophylline | Injection | 25 mg/mL | |
| beclometasone | Inhalation (aerosol) | 250 micrograms (dipropionate) per dose | |
| beclometasone | Inhalation (aerosol) | 50 mcg (dipropionate) per dose (as CFC free forms) | |
| budesonide | Solution for inhalation | 0.5 mg/ml x 2 ml | |
| formoterol | Inhalation (aerosol) | 12 mcg | |
| ipratropium bromide | Inhalation (aerosol) | 20 micrograms/metered dose | |
| ipratropium bromide | Solution | 250 mcg/ ml | |
| salbutamol | Inhalation (aerosol) | 100 mcg (as sulfate) per dose | |
| salbutamol | respirator solution for use in nebulizers | 0.5% | |
| theophylline | Tablet (prolonged release) | 250 mg | |
| triamcinolone | Nasal spray | 55 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorphenamine | Injection | 10mg/ml | |
| chlorphenamine | Oral liquid | 2mg/5ml | |
| chlorphenamine | Tablet | 4 mg (hydrogen maleate) | |
| dimenhydrinate | Injection | 50 mg/mL | |
| dimenhydrinate | Tablet | 50 mg | |
| diphenhydramine | Injection | 50 mg/mL | |
| loratadine | Oral liquid | 5 mg/mL | |
| loratadine | Tablet | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| surfactant | Suspension for intratracheal instillation | 25 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atropine | Injection | 0.5 mg (sulphate) in 1-mL ampoule | |
| atropine | Injection | 5 mg/mL | |
| hyoscine butylbromide | Injection | 20 mg/ml in 1-mL ampoule | |
| hyoscine butylbromide | Tablet | 10mg | |
| metoclopramide | Injection | 5 mg/ml (hydrochloride) | |
| metoclopramide | Tablet | 10 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| omeprazole | Capsule | 20 mg | |
| omeprazole | Capsule | 20 mg | |
| omeprazole | Injection | 40 mg | |
| ranitidine | Injection | 50 mg | |
| ranitidine | Oral liquid | 75 mg/5 mL (as hydrochloride) | |
| ranitidine | Tablet | 150 mg (as hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carbon activado | N/A | N/A | |
| loperamide | Solid oral dosage form | 2mg | |
| nystatin | Oral suspension | 100 000 units/ ml | |
| oral rehydration salts | Powder for dilution | 1 L | |
| sulphasalazine enteric coated | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ondansetron | Injection | 2 mg/ml | |
| ondansetron | Solid oral dosage form | Eq 8 mg base |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| glibenclamide | Tablet | 5 mg | |
| insulin soluble | N/A | 100 units/ml | |
| metformin | Tablet | 850 mg (hydrochloride) | |
| NPH insulin (intermediate-acting insulin) | Injection | 100 IU/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| lactulose | Aqueous emulsion | 10g/15mL | |
| psyllium Hydrofílic Muciloid Isphagula seeds | N/A | N/A | |
| ricin oil | Oily solution | N/A | |
| sodium phosphate monobasic sodium phosphate dibasic | Aqueous emulsion | (19+7)g/118mL | |
| sodium phosphate monobasic sodium phosphate dibasic | enema | (16+6) % | |
| sodium phosphate monobasic sodium phosphate dibasic | sodium phosphate monobasic sodium phosphate dibasic | (2.4 + 0.9) g/5 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| calcium carbonate | Tablet | 600 mg | |
| calcium gluconate | Injection | 10% | |
| zinc | Oral liquid | 10mg/5ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bile salts | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ascorbic acid | Tablet | 500 mg | |
| calcitriol | Capsule | 0.25 mcg | |
| calcitriol | Capsule | 50000 UI | |
| multivitamins | Oral liquid | N/A | c2 |
| multivitamins | Powder for injection | N/A | |
| multivitamins | Tablet | N/A | |
| pyridoxine | Tablet | 50mg (chlorohydrate) | |
| thiamine | Injection | 100mg (chlorohydrate)/ml | |
| thiamine | Tablet | 100mg | |
| vitamin E | Capsule | 400 mg | c2 |
| vitamin E | Powder sachet | 400 UI | c2 |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| tuberculin, purified protein derivative (PPD) | Subcutaneous administration | 2 TU/0.1 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amino acids | Parenteral formulation | 10% | |
| amino acids | Parenteral solution | 3% with gycerol and electrolites | |
| amino acids | Solution | < 6mEq/L< 5.4 mEq/L, Cloro < 3mEq/L 6% | |
| lipid emulsion | Injection | 20% | |
| oligoelements | Parenteral solution | for nutrition, according to availability |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylcysteine | Oral liquid | 20% | |
| calcium acetate | Tablet | 450-500mg | |
| calcium folinate | Injection | 10 mg/ml | |
| deferoxamine | Powder for injection | 500 mg | |
| dimercaprol | Injection in oil | 50 mg/mL in 2-mL ampoule | |
| flumazenil | Injection | 0.1 mg/ml | |
| mesna | Injection | 100 mg/ml | |
| methylene blue | Aqueous solution | 1% | |
| naloxone | Injection | 0.4 mg/mL | |
| protamine sulfate | Injection | 10 mg/mL | |
| sodium calcium edetate | Injection | 200 mg/ml in 5-ml ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| sterile solution for irrigation | Solution for injection | 10mL | |
| sterile solution for irrigation | Solution for injection | 50 mL |